Software that handles health information may fall under more than one regulatory scheme. The relevant schemes depend on the product’s functions, the people or organizations whose information it holds, and how it describes those functions. A health app, wellness tool, or telehealth service may raise different issues because of its data relationships, outputs, and clinical structure. Reviewing those matters before development usually costs less than changing the product after it is built.

Identify the data relationship

The first question is whether the developer is a covered entity or a business associate under HIPAA. That classification helps determine which requirements apply to the product’s handling of health information. The analysis should focus on the developer’s actual role and relationships, rather than the product’s label.

An app sold directly to consumers may fall outside HIPAA when users provide the information voluntarily. That result does not end the privacy analysis. The product still needs to account for the privacy statements it makes to users, including statements about its information practices. The Federal Trade Commission may evaluate those statements, and state privacy statutes increasingly address health data independently.

This distinction affects product planning. The developer needs to determine whether the app operates within a relationship covered by HIPAA or functions as a direct-to-consumer product whose privacy statements and state requirements receive primary attention. That determination may affect how the product describes its information practices and how the developer explains the service to users.

The analysis becomes more complicated when an app sits in front of clinical care. The developer should separate the app’s data practices from the role of the clinician who provides care through or alongside the service. That boundary belongs in the initial product review, not after the service has been built. For a related discussion of where privacy obligations begin when building a health app, see where privacy obligations begin.

Define the software’s function

The second question is whether the software qualifies as a medical device. The product’s function is central to that assessment. Software that analyzes data and gives a specific diagnostic or treatment recommendation moves closer to regulation. Software that displays information or supports administrative tasks generally does not.

These functions require separate analysis. A display tool gives someone material to review. A tool that analyzes data and gives a specific recommendation performs a different task. Both products may use similar data, but classification can depend on the output and how the software uses that data.

Before characterizing the product, developers should describe its actual outputs. That description should state what the software displays, what administrative work it supports, and whether it gives a specific diagnostic or treatment recommendation. Product language should correspond to those functions. A broad label such as “health app” or “wellness tool” does not provide enough detail.

The terms of service should state clearly what the product does and does not do. Users need a service description that matches the product’s operation and explains its limits. Terms of service do not replace an assessment of the software’s function, but they can reduce the risk that the description suggests capabilities the product does not provide.

Map the clinical role

Licensed clinicians create questions about clinical practice beyond the software’s functions. The developer should review how the app and clinical work fit together. Placing an interface in front of a clinician does not, by itself, define the division between the software’s role and the clinician’s role.

Most telehealth weight-loss programs place an app in front of a prescribing clinician. The Medicare telehealth coverage framework may be relevant to the service structure. The amount of clinical contact users receive differs among programs. That difference forms part of the service structure and should appear in the program’s description.

For users comparing those programs, modern medication costs at different program price points are one factor among the features included in the service. The amount of clinical contact may also distinguish one program from another. The way the app supports the prescribing clinician can create another difference.

The same structure affects product descriptions. The app should not suggest that users receive more clinical contact or clinician involvement than the program provides. The terms of service and other user-facing communications should explain the relationship between the software and the prescribing clinician in plain language.

Make the analysis part of planning

The regulatory review should start with the product’s actual structure. First, determine whether the developer is a covered entity or business associate under HIPAA, or whether the product is a direct-to-consumer service whose privacy statements and state privacy statutes receive primary attention. Next, assess the software’s outputs. The review should distinguish software that analyzes data and gives a specific diagnostic or treatment recommendation from software that mainly displays information and supports administrative tasks.

The developer should then map the role of any licensed clinicians. For telehealth weight-loss services, that review includes the app’s position in front of the prescribing clinician and the amount of clinical contact available through the program. The terms of service should explain the product’s functions and limits in plain language. Other descriptions should remain consistent with the service as it operates.

These questions affect one another. Data relationships affect privacy statements. Software outputs affect the medical-device analysis. Clinician involvement raises questions about clinical practice. Reviewing all three areas before development costs less than changing the product after its data practices, functions, and clinical workflow have been established.